bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Figure 1 from Molecular Modulation of Estrogen-Induced Apoptosis by Synthetic Progestins in Hormone Replacement Therapy: An Insight into the Women's Health Initiative Study
Authors: Sweeney Elizabeth E. , Fan Ping , Jordan V. Craig
Published: March 2023

Supplementary Figure 1. A. MCF-7:WS8 and MCF-7:5C cells were treated with either vehicle for 72 hours or 1nM E2 for 24 or 72 hours. Cells were then harvested, and ERα, PR, and GR proteins were measured by Western blot. MCF-7:WS8 cells were used as a positive control for PR expression. B. MCF-7:5C cells were treated with vehicle, 1nM E2, 1µM Dex, MPA, or NETA, or combinations of 1nM E2 plus 1µM Dex, MPA, or NETA for two months. Cells were harvested, proteins were extracted, and Western blots for ERα and GR protein levels were performed. β-actin was used as a loading control.
Supplementary Figures 1 - 9, Tables 1 - 6 from Identification of Prognostic Groups in High-Grade Serous Ovarian Cancer Treated with Platinum–Taxane Chemotherapy
Authors: Chen Ping , Huhtinen Kaisa , Kaipio Katja , Mikkonen Piia , Aittomäki Viljami , Lindell Rony , Hynninen Johanna , Auranen Annika , Grénman Seija , Lehtonen Rainer , Carpén Olli , Hautaniemi Sampsa
Published: March 2023

Supplementary Figure S1. Outcome of PSFinder. Supplementary Figure S2. Kaplan-Meier survival curves. Supplementary Figure S3. Kaplan-Meier survival curves on time to progression in month. Supplementary Figure S4. Expression boxplot of validated transcript markers. Supplementary Figure S5. Promoter methylation changes. Supplementary Figure S6. Expression of genes affected by promoter hyper- and hypo- methylation. Supplementary Figure S7. DNMT3B expression. Supplementary Figure S8. Decitabine treatment result. Supplementary Figure S9. Kaplan-Meier survival curves on overall survival time. Tables Supplementary Table S1. PSFinder identified 61 transcripts at isoform-level for Poor I, Poor II and Good prognostic patient characterization. Supplementary Table S2. PSFinder identified 32 genes at gene-level for Poor I, Poor II and Good prognostic patient characterization. Supplementary Table S3. CpG loci with promoter hypermethylation (N=32) and hypomethylation (N=1) in Poor I patients. Supplementary Table S4. Primers and probes used in Taqman qRT-PCR. Supplementary Table S5. PSFinder identified subgroups and BRCA1/2 mutation status in patients from the TCGA discovery set. Supplementary Table S6. LPS predicted subgroups and BRCA1/2 mutation status in patients from the TCGA validation set.
Supplementary Figure Legends from Vacuolar-ATPase Inhibition Blocks Iron Metabolism to Mediate Therapeutic Effects in Breast Cancer
Authors: Schneider Lina S. , von Schwarzenberg Karin , Lehr Thorsten , Ulrich Melanie , Kubisch-Dohmen Rebekka , Liebl Johanna , Trauner Dirk , Menche Dirk , Vollmar Angelika M.
Published: March 2023

Supplementary Figure Legends. Legend for Supplementary Figures S1-S7.
Supplemental Table S1 from Enhanced Chemokine Receptor Recycling and Impaired S1P1 Expression Promote Leukemic Cell Infiltration of Lymph Nodes in Chronic Lymphocytic Leukemia
Authors: Patrussi Laura , Capitani Nagaja , Martini Veronica , Pizzi Marco , Trimarco Valentina , Frezzato Federica , Marino Filippo , Semenzato Gianpietro , Trentin Livio , Baldari Cosima T.
Published: March 2023

List of the primers used in this study.
Supplemental Tables 1 - 2 from Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis
Authors: Wettersten Hiromi I. , Hakimi A. Ari , Morin Dexter , Bianchi Cristina , Johnstone Megan E. , Donohoe Dallas R. , Trott Josephine F. , Aboud Omran Abu , Stirdivant Steven , Neri Bruce , Wolfert Robert , Stewart Benjamin , Perego Roberto , Hsieh James J. , Weiss Robert H.
Published: March 2023

Absolute values and statistics for quantitative acylcarnitine data. Absolute values and statistics for quantitative GSH and GSSG data.
Supplementary Figure S4 from Definition of Prostaglandin E2–EP2 Signals in the Colon Tumor Microenvironment That Amplify Inflammation and Tumor Growth
Authors: Ma Xiaojun , Aoki Tomohiro , Tsuruyama Tatsuaki , Narumiya Shuh
Published: March 2023

Supplementary Figure S4. Expression of BDNF, Osteopontin and COX-2 in colon from mice without AOM/DSS treatment.
Supplemental Figure S4 from Syntheses and Discovery of a Novel Class of Cinnamic Hydroxamates as Histone Deacetylase Inhibitors by Multimodality Molecular Imaging in Living Subjects
Authors: Chan C.T. , Qi J. , Smith W. , Paranol R. , Mazitschek R. , West N. , Reeves R. , Chiosis G. , Schreiber S.L. , Bradner J.E. , Paulmurugan R. , Gambhir S.S.
Published: March 2023

Supplemental Figure S4. Up-regulation of HDAC biomarkers (p21waf1 and acetylated H3), Hsp70 and NRL-p23 fusion reporter in cells treated with lead HDAC inhibitors.
Supplementary Figure S3 from Definition of Prostaglandin E2–EP2 Signals in the Colon Tumor Microenvironment That Amplify Inflammation and Tumor Growth
Authors: Ma Xiaojun , Aoki Tomohiro , Tsuruyama Tatsuaki , Narumiya Shuh
Published: March 2023

Supplementary Figure S3. NF-κB activation in neutrophils and EP2-dependent expression of pro-inflammatory genes.
Supplementary Figure S2 from Definition of Prostaglandin E2–EP2 Signals in the Colon Tumor Microenvironment That Amplify Inflammation and Tumor Growth
Authors: Ma Xiaojun , Aoki Tomohiro , Tsuruyama Tatsuaki , Narumiya Shuh
Published: March 2023

Supplementary Figure S2. Specificity of anti-EP2 antibody used and the major subpopulation of Gr-1+ cells in the colon.
Supplementary Figure Legends from Definition of Prostaglandin E2–EP2 Signals in the Colon Tumor Microenvironment That Amplify Inflammation and Tumor Growth
Authors: Ma Xiaojun , Aoki Tomohiro , Tsuruyama Tatsuaki , Narumiya Shuh
Published: March 2023

Supplementary Figure Legends. Legend for Supplementary Figures S1-S4.
Supplemental Figures S1-S8 from The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers
Authors: Légaré Stéphanie , Cavallone Luca , Mamo Aline , Chabot Catherine , Sirois Isabelle , Magliocco Anthony , Klimowicz Alexander , Tonin Patricia N. , Buchanan Marguerite , Keilty Dana , Hassan Saima , Laperrière David , Mader Sylvie , Aleynikova Olga , Basik Mark
Published: March 2023

SPEN is mutated in T47D cells (S1); SPEN is down-regulated and mutated in breast cancer (S2); SPEN regulates cell growth and survival (S3); SPEN knockdown in triple negative breast cancer cell lines limits proliferation (S4); SPEN regulates cell death and survival (S5); SPEN regulates transcriptional activity of the Estrogen Receptor (S6); SPEN regulates response of ERα-positive breast cancer cells to tamoxifen (S7); SPEN does not affect ERα-positive breast cancer cells response to fulvestrant (S8).
Supplemental video 1 from ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy
Authors: Messai Yosra , Noman Muhammad Zaeem , Hasmim Meriem , Janji Bassam , Tittarelli Andrés , Boutet Marie , Baud Véronique , Viry Elodie , Billot Katy , Nanbakhsh Arash , Ben Safta Thouraya , Richon Catherine , Ferlicot Sophie , Donnadieu Emmanuel , Couve Sophie , Gardie Betty , Orlanducci Florence , Albiges Laurence , Thiery Jerome , Olive Daniel , Escudier Bernard , Chouaib Salem
Published: March 2023

Supplemental video 1. 786-0 cells described in Figure 3B were recorded by time-lapse video microscopy
Supplementary Tables 3-6 from High-Frequency Targetable EGFR Mutations in Sinonasal Squamous Cell Carcinomas Arising from Inverted Sinonasal Papilloma
Authors: Udager Aaron M. , Rolland Delphine C.M. , McHugh Jonathan B. , Betz Bryan L. , Murga-Zamalloa Carlos , Carey Thomas E. , Marentette Lawrence J. , Hermsen Mario A. , DuRoss Kathleen E. , Lim Megan S. , Elenitoba-Johnson Kojo S.J. , Brown Noah A.
Published: March 2023

Univariate Cox regression analysis for ISP progression to SNSCC, Multivariate Cox regression analysis for ISP progression to SNSCC, Summary of EGFR mutation status and clinicopathologic features of a large ISP cohort.
Supplementary Figure 6 from CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus
Authors: Russell Mike R. , Penikis Annalise , Oldridge Derek A. , Alvarez-Dominguez Juan R. , McDaniel Lee , Diamond Maura , Padovan Olivia , Raman Pichai , Li Yimei , Wei Jun S. , Zhang Shile , Gnanchandran Janahan , Seeger Robert , Asgharzadeh Shahab , Khan Javed , Diskin Sharon J. , Maris John M. , Cole Kristina A.
Published: March 2023

Additional cell lines showing increased neuroblastoma cell growth following CASC15-S depletion.
Supplementary Figure 2 from CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus
Authors: Russell Mike R. , Penikis Annalise , Oldridge Derek A. , Alvarez-Dominguez Juan R. , McDaniel Lee , Diamond Maura , Padovan Olivia , Raman Pichai , Li Yimei , Wei Jun S. , Zhang Shile , Gnanchandran Janahan , Seeger Robert , Asgharzadeh Shahab , Khan Javed , Diskin Sharon J. , Maris John M. , Cole Kristina A.
Published: March 2023

Bioinformatical support for CASC15-S as a long noncoding transcript.
Supplementary Figure 1 from Pharmacological Inhibition of β3 Integrin Reduces the Inflammatory Toxicities Caused by Oncolytic Adenovirus without Compromising Anticancer Activity
Authors: Browne Ashley , Tookman Laura A. , Ingemarsdotter Carin K. , Bouwman Russell D. , Pirlo Katrina , Wang Yaohe , McNeish Iain A. , Lockley Michelle
Published: March 2023

SKOV3ip1 cells were infected in duplicate with dl922-947 (MOI 10 and MOI 100), Ad5 WT (MOI 10 and MOI 100) or vehicle. Cell supernatants were analysed for cytokine levels using the Mesoscale system at 3 hours and 6 hours post infection.
Supplementary Tables S1-S5 from NKX3.1 Suppresses TMPRSS2–ERG Gene Rearrangement and Mediates Repair of Androgen Receptor–Induced DNA Damage
Authors: Bowen Cai , Zheng Tian , Gelmann Edward P.
Published: March 2023

Supplementary Tables S1-S5. RT-PCR primers (S1); Real time PCR primers (S2); ChIP PCR primers (S3); 3C primers (S4); ANOVA p-Values for ChIP Assays (S5).
Supplemental Figure 5 from Neutrophil Extracellular Traps Accumulate in Peripheral Blood Vessels and Compromise Organ Function in Tumor-Bearing Animals
Authors: Cedervall Jessica , Zhang Yanyu , Huang Hua , Zhang Lei , Femel Julia , Dimberg Anna , Olsson Anna-Karin
Published: March 2023

Supplemental Figure 5: Anti-G-CSF treatment restores kidney vascular function in MMTV-PyMT mice.
Supplemental Figure 3 from Neutrophil Extracellular Traps Accumulate in Peripheral Blood Vessels and Compromise Organ Function in Tumor-Bearing Animals
Authors: Cedervall Jessica , Zhang Yanyu , Huang Hua , Zhang Lei , Femel Julia , Dimberg Anna , Olsson Anna-Karin
Published: March 2023

Supplemental Figure 3: DNase treatment restores vascular function in kidneys from RIP1-Tag2 mice.
Supplemental Figure 1 from Neutrophil Extracellular Traps Accumulate in Peripheral Blood Vessels and Compromise Organ Function in Tumor-Bearing Animals
Authors: Cedervall Jessica , Zhang Yanyu , Huang Hua , Zhang Lei , Femel Julia , Dimberg Anna , Olsson Anna-Karin
Published: March 2023

Supplemental Figure 1: Neutrophils are effectively depleted after treatment with anti-Gr1 targeting antibodies.
Supplementary Table S1 from Oncogenic Transformation Can Orchestrate Immune Evasion and Inflammation in Human Mesenchymal Stem Cells Independently of Extrinsic Immune-Selective Pressure
Authors: Miranda Alex , Funes Juan M. , Sánchez Nilda , Limia Celia M. , Mesa Mónica , Quezada Sergio A. , Pérez Rolando , de León Joel
Published: March 2023

Supplementary Table S1. Probe Set IDs for microarray's analysis.
Supplementary Figure Legends from CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated Cytotoxicity
Authors: Yang Chenyi , Boyson Cynthia A. , Di Liberto Maurizio , Huang Xiangao , Hannah Jeffrey , Dorn David C. , Moore Malcolm A.S. , Chen-Kiang Selina , Zhou Pengbo
Published: March 2023

Legend for Supplementary Figures S1-S2.
Supplementary Figure S4 from TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
Authors: Drasin David J. , Guarnieri Anna L. , Neelakantan Deepika , Kim Jihye , Cabrera Joshua H. , Wang Chu-An , Zaberezhnyy Vadym , Gasparini Pierluigi , Cascione Luciano , Huebner Kay , Tan Aik-Choon , Ford Heide L.
Published: March 2023

Supplementary Figure S4 Inducible miR-424 recapitulates constitutive miR-424 EMT and TIC phenotypes reversibly. SUM149PT clones with i-EV or i-miR-424 constructs were assayed for a variety of EMT parameters: (A) 3' UTR luciferase reporter with perfect or mutant miR-424 binding sites after a doxycycline induction (induction shown in Figure 2H) followed by doxycycline removal; (B) cell cycle analysis, by PI staining (G1 shown); (C) gap closure at eight hours; (D) flow cytometry for the TIC marker ALDH1. Doxycycline and reversed conditions were treated with 0.5 ÃŽÂ¼g/mL doxycycline for 7-10 days, while reversed conditions were cultured for an additional 7-10 days in the absence of doxycycline. SEM, shown. *p<0.05, **p<0.01, ***p<0.001. Two-way ANOVA, Bonferroni multiple comparison post-test for all.
Supplementary Figure 2 from Correlation between Density of CD8+ T-cell Infiltrate in Microsatellite Unstable Colorectal Cancers and Frameshift Mutations: A Rationale for Personalized Immunotherapy
Authors: Maby Pauline , Tougeron David , Hamieh Mohamad , Mlecnik Bernhard , Kora Hafid , Bindea Gabriela , Angell Helen K. , Fredriksen Tessa , Elie Nicolas , Fauquembergue Emilie , Drouet Aurélie , Leprince Jérôme , Benichou Jacques , Mauillon Jacques , Le Pessot Florence , Sesboüé Richard , Tuech Jean-Jacques , Sabourin Jean-Christophe , Michel Pierre , Frébourg Thierry , Galon Jérôme , Latouche Jean-Baptiste
Published: March 2023

Correlation between frameshift mutations and CD8+ TIL density in the second series.
Supplementary Figure S2 from RAGE Mediates S100A7-Induced Breast Cancer Growth and Metastasis by Modulating the Tumor Microenvironment
Authors: Nasser Mohd W. , Wani Nissar Ahmad , Ahirwar Dinesh K. , Powell Catherine A. , Ravi Janani , Elbaz Mohamad , Zhao Helong , Padilla Laura , Zhang Xiaoli , Shilo Konstantin , Ostrowski Michael , Shapiro Charles , Carson William E. , Ganju Ramesh K.
Published: March 2023

RAGE regulates macrophage recruitment.
Supplementary Figure 3 from Tumor-Derived Osteopontin Reprograms Normal Mammary Fibroblasts to Promote Inflammation and Tumor Growth in Breast Cancer
Authors: Sharon Yoray , Raz Yael , Cohen Noam , Ben-Shmuel Amir , Schwartz Hila , Geiger Tamar , Erez Neta
Published: March 2023

Figure S3: Knockdown of OPN does not affect tumor cell growth in vitro.
Supplementary Figure S1 from Acute Tissue Injury Activates Satellite Cells and Promotes Sarcoma Formation via the HGF/c-MET Signaling Pathway
Authors: Van Mater David , Añó Leonor , Blum Jordan M. , Webster Micah T. , Huang WeiQiao , Williams Nerissa , Ma Yan , Cardona Diana M. , Fan Chen-Ming , Kirsch David G.
Published: March 2023

Supplementary Figure S1. Optimization of cardiotoxin volume and concentration.
Supplementary Figure S9 from PIK3CAH1047R Accelerates and Enhances KRASG12D-Driven Lung Tumorigenesis
Authors: Green Shon , Trejo Christy L. , McMahon Martin
Published: March 2023

Inhibitory effects of BYL719 on tumorigenesis and signaling in human KRASQ61H/PIK3CAE545K-driven H460 lung cancer cells.
Supplementary Figures 1 - 6, Table 1 from Epigenetic Activation of TWIST1 by MTDH Promotes Cancer Stem–like Cell Traits in Breast Cancer
Authors: Liang Yajun , Hu Jing , Li Jiatao , Liu Yingjie , Yu Jingyi , Zhuang Xueqian , Mu Lili , Kong Xiangyin , Hong Dengli , Yang Qifeng , Hu Guohong
Published: March 2023

Fig. S1. CSC abundance, expression of ABC transporters and cancer cell chemoresistance after MTDH knockdown or overexpression. Fig. S2. Expression of EMT marker proteins after MTDH knockdown or overexpression. Fig. S3. CSC abundance and in vivo tumorigencity of DU145 cells after MTDH knockdown. Fig. S4. TWIST1 expression was regulated by histone acetylation. Fig. S5. The CBP homolog p300 was not involved in MTDH regulation of TWIST1. Fig. S6. TWIST1+ cells are co-localized with MTDH+ cells at invasive tumor front (ITF). Table S1: The sequences of primers and shRNA constructs used in the study.
Supplementary Figure 5 from IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras–Mutant Lung Cancer
Authors: Caetano Mauricio S. , Zhang Huiyuan , Cumpian Amber M. , Gong Lei , Unver Nese , Ostrin Edwin J. , Daliri Soudabeh , Chang Seon Hee , Ochoa Cesar E. , Hanash Samir , Behrens Carmen , Wistuba Ignacio I. , Sternberg Cinthya , Kadara Humam , Ferreira Carlos Gil , Watowich Stephanie S. , Moghaddam Seyed Javad
Published: March 2023

Supplementary Figure 5. Relative expression of Arg1 mRNA normalized by Cd45 expression in lungs of CC-LR mice.
Supplementary Table 1 from Aberrant Expression of proPTPRN2 in Cancer Cells Confers Resistance to Apoptosis
Authors: Sorokin Alexey V. , Nair Binoj C. , Wei Yongkun , Aziz Kathryn E. , Evdokimova Valentina , Hung Mien-Chie , Chen Junjie
Published: March 2023

ProPTPRN2, mature PTPRN2, or proPTPRN2 (DPTP)-associated proteins identified by mass spectrometry analysis in stable MDA-MB-468 cells.
Supplementary Figures 1-6 from Aberrant Expression of proPTPRN2 in Cancer Cells Confers Resistance to Apoptosis
Authors: Sorokin Alexey V. , Nair Binoj C. , Wei Yongkun , Aziz Kathryn E. , Evdokimova Valentina , Hung Mien-Chie , Chen Junjie
Published: March 2023

Supplementary Figures 1-6 Supplementary Figure 1. PTPRN2 expression in normal and cancer tissues. Supplementary Figure 2. Validation of PTPRN2 antibodies for immunohistochemistry (IHC) and Western blot (WB) analysis. Supplementary Figure 3. MCF10A cells expressing proPTPRN2 forms larger acinar structures in Matrigel. Supplementary Figure 4. PTPRN2 is involved in IϰB/NF-ϰB and c-Jun N-terminal kinase (JNK)/AP-1 signaling pathways. Supplementary Figure 5. PTPRN2 knockdown induces apoptosis in MDA-MB-468 cells. Supplementary Figure 6. Overexpression of proPTPRN2 but not mature PTPRN2 suppresses TRAF2 phosphorylation.
Supplementary Figure S5 from Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations
Authors: Emir Uzay E. , Larkin Sarah J. , de Pennington Nick , Voets Natalie , Plaha Puneet , Stacey Richard , Al-Qahtani Khalid , Mccullagh James , Schofield Christopher J. , Clare Stuart , Jezzard Peter , Cadoux-Hudson Tom , Ansorge Olaf
Published: March 2023

LCmodel analysis between 3.9 and 0.5 ppm.
Supplemental Figure Legends from A Quantitative System for Studying Metastasis Using Transparent Zebrafish
Authors: Heilmann Silja , Ratnakumar Kajan , Langdon Erin M. , Kansler Emily R. , Kim Isabella S. , Campbell Nathaniel R. , Perry Elizabeth B. , McMahon Amy J. , Kaufman Charles K. , van Rooijen Ellen , Lee William , Iacobuzio-Donahue Christine A. , Hynes Richard O. , Zon Leonard I. , Xavier Joao B. , White Richard M.
Published: March 2023

These are the legends for Supplemental Figures 1-20
Supplemetary Video S2 from Snail1-Expressing Fibroblasts in the Tumor Microenvironment Display Mechanical Properties That Support Metastasis
Authors: Stanisavljevic Jelena , Loubat-Casanovas Jordina , Herrera Mercedes , Luque Tomás , Peña Raúl , Lluch Ana , Albanell Joan , Bonilla Félix , Rovira Ana , Peña Cristina , Navajas Daniel , Rojo Federico , García de Herreros Antonio , Baulida Josep
Published: March 2023

Video S2. MDA-MB231 cells on 3D-ECM generated by TGFÃŽÂ²-treated Control MEFs.
Supplementary Figure Legends from Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
Authors: Hughes Russell , Qian Bin-Zhi , Rowan Charlotte , Muthana Munitta , Keklikoglou Ioanna , Olson Oakley C. , Tazzyman Simon , Danson Sarah , Addison Christina , Clemons Mark , Gonzalez-Angulo Ana Maria , Joyce Johanna A. , De Palma Michele , Pollard Jeffrey W. , Lewis Claire E.
Published: March 2023

Supplementary Figure Legends from Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
Supplementary Figures S1-S4 from Mitochondrial DNA Repair through OGG1 Activity Attenuates Breast Cancer Progression and Metastasis
Authors: Yuzefovych Larysa V. , Kahn Andrea G. , Schuler Michele A. , Eide Lars , Arora Ritu , Wilson Glenn L. , Tan Ming , Rachek Lyudmila I.
Published: March 2023

Representative images of each genotype of PyMT mice with mammary tumors obtained from 12-16-week old female (S1); Histological sections of the lungs from PyMT mice of different OGG1 genotypes (S2); OGG1 activity in mammary tumors isolated from B-nuclear, and D- mitochondrial fractions from PyMT/KO and PyMT/Tg animals (S3); LDH activity in mammary tumors isolated from PyMT/KO, PyMT/WT, PyMT/Tg and PyMT/ KOTg mice (S4).
Supplementary Table S6 from Identification of P450 Oxidoreductase as a Major Determinant of Sensitivity to Hypoxia-Activated Prodrugs
Authors: Hunter Francis W. , Young Richard J. , Shalev Zvi , Vellanki Ravi N. , Wang Jingli , Gu Yongchuan , Joshi Naveen , Sreebhavan Sreevalsan , Weinreb Ilan , Goldstein David P. , Moffat Jason , Ketela Troy , Brown Kevin R. , Koritzinsky Marianne , Solomon Benjamin , Rischin Danny , Wilson William R. , Wouters Bradly G.
Published: March 2023

Spearman correlation of expression of flavoproteins with SN30000 metabolism in tumor cell lines.
Supplementary Material from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
Authors: Alford Sarah E. , Kothari Anisha , Loeff Floris C. , Eichhorn Joshua M. , Sakurikar Nandini , Goselink Henriette M. , Saylors Robert L. , Jedema Inge , Falkenburg J.H. Frederik , Chambers Timothy C.
Published: March 2023

Portions of Methods and Materials and supplementary figure legends
Supplemental Figure 5 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
Authors: Alford Sarah E. , Kothari Anisha , Loeff Floris C. , Eichhorn Joshua M. , Sakurikar Nandini , Goselink Henriette M. , Saylors Robert L. , Jedema Inge , Falkenburg J.H. Frederik , Chambers Timothy C.
Published: March 2023

Supplemental Figure 5: ABT-263 displaces Bim from Bcl-2 within cells.
Supplemental Figure 4 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
Authors: Alford Sarah E. , Kothari Anisha , Loeff Floris C. , Eichhorn Joshua M. , Sakurikar Nandini , Goselink Henriette M. , Saylors Robert L. , Jedema Inge , Falkenburg J.H. Frederik , Chambers Timothy C.
Published: March 2023

Supplemental Figure 4: Pro-apoptotic Bcl-2 family proteins are absent in β-actin immunoprecipitates.
Supplemental Table S3 from miR-339-3p Is a Tumor Suppressor in Melanoma
Authors: Weber Claudia E.M. , Luo Chonglin , Hotz-Wagenblatt Agnes , Gardyan Adriane , Kordaß Theresa , Holland-Letz Tim , Osen Wolfram , Eichmüller Stefan B.
Published: March 2023

In silico analysis of miR-339-3p targets.
Supplementary Table 1 from Identification of a Functional SNP in the 3′UTR of CXCR2 That Is Associated with Reduced Risk of Lung Cancer
Authors: Ryan Bríd M. , Robles Ana I. , McClary Andrew C. , Haznadar Majda , Bowman Elise D. , Pine Sharon R. , Brown Derek , Khan Mohammed , Shiraishi Kouya , Kohno Takashi , Okayama Hirokazu , Modali Ramakrishna , Yokota Jun , Harris Curtis C.
Published: March 2023

List of genes included in the study.
Supplementary Figure 4 from Identification of a Functional SNP in the 3′UTR of CXCR2 That Is Associated with Reduced Risk of Lung Cancer
Authors: Ryan Bríd M. , Robles Ana I. , McClary Andrew C. , Haznadar Majda , Bowman Elise D. , Pine Sharon R. , Brown Derek , Khan Mohammed , Shiraishi Kouya , Kohno Takashi , Okayama Hirokazu , Modali Ramakrishna , Yokota Jun , Harris Curtis C.
Published: March 2023

CXCR2 isoform expression predicted by Emsembl.
Supplementary Table S1 from Genetic and Pharmacologic Inhibition of eIF4E Reduces Breast Cancer Cell Migration, Invasion, and Metastasis
Authors: Pettersson Filippa , del Rincon Sonia V. , Emond Audrey , Huor Bonnie , Ngan Elaine , Ng Jonathan , Dobocan Monica C. , Siegel Peter M. , Miller Wilson H.
Published: March 2023

Supplementary Table S1. Ribavirin concentrations measured in mouse plasma.
Supplementary Figure S5 from Genetic and Pharmacologic Inhibition of eIF4E Reduces Breast Cancer Cell Migration, Invasion, and Metastasis
Authors: Pettersson Filippa , del Rincon Sonia V. , Emond Audrey , Huor Bonnie , Ngan Elaine , Ng Jonathan , Dobocan Monica C. , Siegel Peter M. , Miller Wilson H.
Published: March 2023

Supplementary Figure S5. Knockdown of eIF4E suppresses TGF-B induced ZO-1 destabilization at cellular junctions.
Supplementary Figure S2 from PI3K/mTOR Dual Inhibitor VS-5584 Preferentially Targets Cancer Stem Cells
Authors: Kolev Vihren N. , Wright Quentin G. , Vidal Christian M. , Ring Jennifer E. , Shapiro Irina M. , Ricono Jill , Weaver David T. , Padval Mahesh V. , Pachter Jonathan A. , Xu Qunli
Published: March 2023

Supplementary Figure S2. Side Population of SUM159 cells enriches for tumor-initiating capability.
Supplementary Material and Methods, Figure Legends S1-6 from Reprogramming of the ERRα and ERα Target Gene Landscape Triggers Tamoxifen Resistance in Breast Cancer
Authors: Thewes Verena , Simon Ronald , Schroeter Petra , Schlotter Magdalena , Anzeneder Tobias , Büttner Reinhard , Benes Vladimir , Sauter Guido , Burwinkel Barbara , Nicholson Robert I. , Sinn Hans-Peter , Schneeweiss Andreas , Deuschle Ulrich , Zapatka Marc , Heck Stefanie , Lichter Peter
Published: March 2023

Supplementary Material and Methods, Figure Legends S1-6. Supplementary Material and Methods, Figure Legends S1-6.
Supplementary Figure S4 from The CUL4B/AKT/β-Catenin Axis Restricts the Accumulation of Myeloid-Derived Suppressor Cells to Prohibit the Establishment of a Tumor-Permissive Microenvironment
Authors: Qian Yanyan , Yuan Jupeng , Hu Huili , Yang Qifeng , Li Jisheng , Zhang Shuqian , Jiang Baichun , Shao Changshun , Gong Yaoqin
Published: March 2023

Supplementary Figure S4. The expression level of β-catenin.
Supplemental Materials and Methods from VEGF-A Expression Correlates with TP53 Mutations in Non–Small Cell Lung Cancer: Implications for Antiangiogenesis Therapy
Authors: Schwaederlé Maria , Lazar Vladimir , Validire Pierre , Hansson Johan , Lacroix Ludovic , Soria Jean-Charles , Pawitan Yudi , Kurzrock Razelle
Published: March 2023

Supplemental Materials and Methods. Description of additional methods and procedures used in the study.
SMovie S4 from Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
Authors: Adinolfi Elena , Capece Marina , Franceschini Alessia , Falzoni Simonetta , Giuliani Anna L. , Rotondo Alessandra , Sarti Alba C. , Bonora Massimo , Syberg Susanne , Corigliano Domenica , Pinton Paolo , Jorgensen Niklas R. , Abelli Luigi , Emionite Laura , Raffaghello Lizzia , Pistoia Vito , Di Virgilio Francesco
Published: March 2023

SMovie S4. Migration of wt N13 microglial cells from both sides of a wounded monolayer after scratching with a plastic pipette tip.
Supplementary Figure 5 from eIF4E Threshold Levels Differ in Governing Normal and Neoplastic Expansion of Mammary Stem and Luminal Progenitor Cells
Authors: Avdulov Svetlana , Herrera Jeremy , Smith Karen , Peterson Mark , Gomez-Garcia Jose R. , Beadnell Thomas C. , Schwertfeger Kathryn L. , Benyumov Alexey O. , Manivel J. Carlos , Li Shunan , Bielinsky Anja-Katrin , Yee Douglas , Bitterman Peter B. , Polunovsky Vitaly A.
Published: March 2023

Supplementary Fig. S5. HA-eIF4E rescues HMEC/hTERT cells from Ras-induced senescence and activates ATR signaling.
Supplementary Methods and Reference from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
Authors: Shi Xu-Bao , Ma Ai-Hong , Xue Lingru , Li Meimei , Nguyen Hao G. , Yang Joy C. , Tepper Clifford G. , Gandour-Edwards Regina , Evans Christopher P. , Kung Hsing-Jien , deVere White Ralph W.
Published: March 2023

Description of additional methods and procedures used in the study. Also includes Supplementary Reference.
Supplementary Figure S2 from Immuno-PET Imaging of Engineered Human T Cells in Tumors
Authors: Mall Sabine , Yusufi Nahid , Wagner Ricarda , Klar Richard , Bianchi Henrique , Steiger Katja , Straub Melanie , Audehm Stefan , Laitinen Iina , Aichler Michaela , Peschel Christian , Ziegler Sibylle , Mustafa Mona , Schwaiger Markus , D'Alessandria Calogero , Krackhardt Angela M.
Published: March 2023

Investigation of different imaging time points to track TCR-transduced TCM after injection of 89Zr-aTCRmu-F(ab')2
Supplementary Table S4 from Accumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas
Authors: Hilvo Mika , de Santiago Ines , Gopalacharyulu Peddinti , Schmitt Wolfgang D. , Budczies Jan , Kuhberg Marc , Dietel Manfred , Aittokallio Tero , Markowetz Florian , Denkert Carsten , Sehouli Jalid , Frezza Christian , Darb-Esfahani Silvia , Braicu Elena Ioana
Published: March 2023

Results of statistical tests regarding serum metabolites and nutrition.
Supplementary Table S5 from PDGF Engages an E2F-USP1 Signaling Pathway to Support ID2-Mediated Survival of Proneural Glioma Cells
Authors: Rahme Gilbert J. , Zhang Zhonghua , Young Alison L. , Cheng Chao , Bivona Eric J. , Fiering Steven N. , Hitoshi Yasuyuki , Israel Mark A.
Published: March 2023

Microarray Data (Log2) of Untreated GSC1 and GSC1 Treated with Dox.
Supplementary Materials from Hydroxamic Acid and Benzoic Acid–Based STAT3 Inhibitors Suppress Human Glioma and Breast Cancer Phenotypes In Vitro and In Vivo
Authors: Yue Peibin , Lopez-Tapia Francisco , Paladino David , Li Yifei , Chen Chih-Hong , Hilliard Tyvette , Chen Yuan , Tius Marcus A. , Turkson James
Published: March 2023

Supplementary Materials
Supplementary Figure S13 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial
Authors: Erdem-Eraslan Lale , van den Bent Martin J. , Hoogstrate Youri , Naz-Khan Hina , Stubbs Andrew , van der Spek Peter , Böttcher René , Gao Ya , de Wit Maurice , Taal Walter , Oosterkamp Hendrika M. , Walenkamp Annemiek , Beerepoot Laurens V. , Hanse Monique C.J. , Buter Jan , Honkoop Aafke H. , van der Holt Bronno , Vernhout René M. , Smitt Peter A.E. Sillevis , Kros Johan M. , French Pim J.
Published: March 2023

Example of genomic breakpoints identified by RNA sequencing.
Supplementary Figure S6 from Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin–GUCY2C Paracrine Signaling Axis
Authors: Lin Jieru E. , Colon-Gonzalez Francheska , Blomain Erik , Kim Gilbert W. , Aing Amanda , Stoecker Brian , Rock Justin , Snook Adam E. , Zhan Tingting , Hyslop Terry M. , Tomczak Michal , Blumberg Richard S. , Waldman Scott A.
Published: March 2023

Daily calorie intake, body weights, and guanylin expression in Ob/Ob mice on ad libitum or calorie-restricted diets.
Supplementary Figure S4 from Candidate Antimetastasis Drugs Suppress the Metastatic Capacity of Breast Cancer Cells by Reducing Membrane Fluidity
Authors: Zhao Weina , Prijic Sara , Urban Bettina C. , Tisza Michael J. , Zuo Yan , Li Lin , Tan Zhi , Chen Xiaoling , Mani Sendurai A. , Chang Jeffrey T.
Published: March 2023

ABCA1 is required for metastatic phenotypes in vitro.
Supplementary Data from Candidate Antimetastasis Drugs Suppress the Metastatic Capacity of Breast Cancer Cells by Reducing Membrane Fluidity
Authors: Zhao Weina , Prijic Sara , Urban Bettina C. , Tisza Michael J. , Zuo Yan , Li Lin , Tan Zhi , Chen Xiaoling , Mani Sendurai A. , Chang Jeffrey T.
Published: March 2023

Supplementary Materials and Methods Supplementary Figure Legends Supplementary Table Legends
Supplementary Methods, Table 1, Figure S1-S9 from Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells
Authors: Cojoc Monica , Peitzsch Claudia , Kurth Ina , Trautmann Franziska , Kunz-Schughart Leoni A. , Telegeev Gennady D. , Stakhovsky Eduard A. , Walker John R. , Simin Karl , Lyle Stephen , Fuessel Susanne , Erdmann Kati , Wirth Manfred P. , Krause Mechthild , Baumann Michael , Dubrovska Anna
Published: March 2023

Supplementary Methods, Table 1, Figure S1-S9 (i) supplementary methods: Human tumor tissue dissociation, Immunofluorescence microscopy, Clonogenic cell survival assay, Sphere formation assay, Cell proliferation and cytotoxicity assay, Wound healing assay, Transwell migration assay, Western blot analysis, Flow cytometry analysis, Chromatin immunoprecipitation assay, siRNA-mediated gene silencing, Luciferase reporter assay, Histology, Microarray analysis of the xenograft tumors, (ii) supplementary table 1: Primary tumor tissues used in the study and (iii) supplementary figures including Figure S1 (analysis of ALDH1A1 expression in normal and tumor prostate tissues), Figure S2 (prostate cancer ALDH+ cells possess CSC properties), Figure S3 (analysis of CSC marker expression after irradiation), Figure S4 (clonogenicity and tumorigenisity of ALDH+ and ALDH- cells after irradiation), Figure S5 (characterization of the radioresistant prostate cancer cell sublines), Figure S6 (the mechanisms of prostate cancer cell radioresistance), Figure S7 (comparative gene expression profiling of ALDH+ and radioresistant DU145 cells), Figure S8 (EMT properties of ALDH+ and radioresistant prostate cancer cells), Figure S9 (WNT/β-catenin pathway regulates ALDH1A1 expression)
Supplementary Methods and References from Enhanced Survival with Implantable Scaffolds That Capture Metastatic Breast Cancer Cells In Vivo
Authors: Rao Shreyas S. , Bushnell Grace G. , Azarin Samira M. , Spicer Graham , Aguado Brian A. , Stoehr Jenna R. , Jiang Eric J. , Backman Vadim , Shea Lonnie D. , Jeruss Jacqueline S.
Published: March 2023

Description of additional methods and procedures used in the study. Also includes Supplementary References.
Supplemantal Figures S1-S5 from GPCR Signaling Mediates Tumor Metastasis via PI3Kβ
Authors: Khalil Bassem D. , Hsueh Christine , Cao Yanyan , Abi Saab Widian F. , Wang Yarong , Condeelis John S. , Bresnick Anne R. , Backer Jonathan M.
Published: March 2023

Myc and p110α immunoblots in parental and stable cell lines (S1); Quantitation of immunoblots from Figure 1 (S2); Expression of GPCR-uncoupled or kinase-dead p110β in MDA-MB-231 cells has no effect on breast cancer cell proliferation (S3); Gβγ binding to p110β is required for macrophage-stimulated breast cancer cell migration (S4); Gβγ binding to p110β is required for macrophage-stimulated invasion in T47D cell line (S5).
Supplementary Table S1 from H3K27 Demethylase JMJD3 Employs the NF-κB and BMP Signaling Pathways to Modulate the Tumor Microenvironment and Promote Melanoma Progression and Metastasis
Authors: Park Woo-Yong , Hong Beom-Jin , Lee Jungsul , Choi Chulhee , Kim Mi-Young
Published: March 2023

JMJD3 promotes melanoma initiation.
Supplementary Methods and References from H3K27 Demethylase JMJD3 Employs the NF-κB and BMP Signaling Pathways to Modulate the Tumor Microenvironment and Promote Melanoma Progression and Metastasis
Authors: Park Woo-Yong , Hong Beom-Jin , Lee Jungsul , Choi Chulhee , Kim Mi-Young
Published: March 2023

Additional information on reagents and experimental procedures. Also includes Supplementary References.
Supplementary Figure S2 from H3K27 Demethylase JMJD3 Employs the NF-κB and BMP Signaling Pathways to Modulate the Tumor Microenvironment and Promote Melanoma Progression and Metastasis
Authors: Park Woo-Yong , Hong Beom-Jin , Lee Jungsul , Choi Chulhee , Kim Mi-Young
Published: March 2023

qRT-PCR analysis of JMJD3 candidate target genes.
Supplementary Figure S1 from H3K27 Demethylase JMJD3 Employs the NF-κB and BMP Signaling Pathways to Modulate the Tumor Microenvironment and Promote Melanoma Progression and Metastasis
Authors: Park Woo-Yong , Hong Beom-Jin , Lee Jungsul , Choi Chulhee , Kim Mi-Young
Published: March 2023

Characterization of JMJD3-overexpressing and knockout melanoma cell lines.
Supplemental Meterials and Methods from EF Hand Protein IBA2 Promotes Cell Proliferation in Breast Cancers via Transcriptional Control of Cyclin D1
Authors: Zhang Ying , Wang Shuling , Li Lingsong
Published: March 2023

Supplemental Meterials and Methods
Suppl Table 3 from A Preclinical Model of Malignant Peripheral Nerve Sheath Tumor-like Melanoma Is Characterized by Infiltrating Mast Cells
Authors: Hölzel Michael , Landsberg Jennifer , Glodde Nicole , Bald Tobias , Rogava Meri , Riesenberg Stefanie , Becker Albert , Jönsson Göran , Tüting Thomas
Published: March 2023

Supplementary Table 3. Gene lists of the mouse gene signatures used in this study.
Suppl Table 2 from A Preclinical Model of Malignant Peripheral Nerve Sheath Tumor-like Melanoma Is Characterized by Infiltrating Mast Cells
Authors: Hölzel Michael , Landsberg Jennifer , Glodde Nicole , Bald Tobias , Rogava Meri , Riesenberg Stefanie , Becker Albert , Jönsson Göran , Tüting Thomas
Published: March 2023

Supplementary Table 2. Gene lists of the human gene signatures used in this study.
Supplemental Figure 9 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity
Authors: Kim Dong Joon , Roh Eunmiri , Lee Mee-Hyun , Oi Naomi , Lim Do Young , Kim Myoung Ok , Cho Yong-Yeon , Pugliese Angelo , Shim Jung-Hyun , Chen Hanyong , Cho Eun Jin , Kim Jong-Eun , Kang Sun Chul , Paul Souren , Kang Hee Eun , Jung Ji Won , Lee Sung-Young , Kim Sung-Hyun , Reddy Kanamata , Yeom Young Il , Bode Ann M. , Dong Zigang
Published: March 2023

The effect of herbacetin on AP-1 upstream protein expression. (A-B) Colon tumors were isolated from vehicle- and herbacetin-treated groups (A; treatment by I.P., B: treatment by oral administration) of mice for immunoblot analysis of AP-1 upstream proteins and (C) ODC expression by immunohistochemistry (IHC).
Supplemental Figure Legends from EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer
Authors: Amato Katherine R. , Wang Shan , Tan Li , Hastings Andrew K. , Song Wenqiang , Lovly Christine M. , Meador Catherine B. , Ye Fei , Lu Pengcheng , Balko Justin M. , Colvin Daniel C. , Cates Justin M. , Pao William , Gray Nathanael S. , Chen Jin
Published: March 2023

Legends for Supplemental Figures S1-S6
Supplemental Figure 10 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity
Authors: Kim Dong Joon , Roh Eunmiri , Lee Mee-Hyun , Oi Naomi , Lim Do Young , Kim Myoung Ok , Cho Yong-Yeon , Pugliese Angelo , Shim Jung-Hyun , Chen Hanyong , Cho Eun Jin , Kim Jong-Eun , Kang Sun Chul , Paul Souren , Kang Hee Eun , Jung Ji Won , Lee Sung-Young , Kim Sung-Hyun , Reddy Kanamata , Yeom Young Il , Bode Ann M. , Dong Zigang
Published: March 2023

The effect of herbacetin or DFMO on hearing in C57BL/6 mice as measured by PPI. Vehicle, herbacetin (100 mg/kg B.W. p.o. or 2 mg/kg B.W. i.p.) or DFMO (1 g/kg B.W. p.o.) was administered by gavage or intraperitoneal injection 5 times per week for 5 weeks. (A) DFMO significantly decreased hearing (measured as prepulse inhibition or PPI) on day 35. Hearing as measured by PPI was not affected by oral administration (B) or intraperitoneal injection (C) of herbacetin. Data are shown as mean values {plus minus} S.E. The asterisk (*) indicates a significant decrease (p < 0.05) in hearing in DFMO-treated mice compared to the vehicle-treated group.
Supplementary Figure S3 from Inhibition of PAI-1 Limits Tumor Angiogenesis Regardless of Angiogenic Stimuli in Malignant Pleural Mesothelioma
Authors: Takayama Yusuke , Hattori Noboru , Hamada Hironobu , Masuda Takeshi , Omori Keitaro , Akita Shin , Iwamoto Hiroshi , Fujitaka Kazunori , Kohno Nobuoki
Published: March 2023

Effects of SK-216 on subcutaneous tumors in SCID mice inoculated with MPM cells
Supplementary Figure 1 from Systemic Chromosome Instability Resulted in Colonic Transcriptomic Changes in Metabolic, Proliferation, and Stem Cell Regulators in Sgo1−/+ Mice
Authors: Rao Chinthalapally V. , Sanghera Saira , Zhang Yuting , Biddick Laura , Reddy Arun , Lightfoot Stan , Janakiram Naveena B. , Mohammed Altaf , Dai Wei , Yamada Hiroshi Y.
Published: March 2023

List of 349 differentially expressed genes in normal-looking colonic mucosal tissues in Sgo1, compared with control wild type. (P<0.05, 2-fold cutoff)
Supplementary Methods and References from An Atlas of the Human Kinome Reveals the Mutational Landscape Underlying Dysregulated Phosphorylation Cascades in Cancer
Authors: Olow Aleksandra , Chen Zhongzhong , Niedner R. Hannes , Wolf Denise M. , Yau Christina , Pankov Aleksandr , Lee Evelyn Pei Rong , Brown-Swigart Lamorna , van ‘t Veer Laura J. , Coppé Jean-Philippe
Published: March 2023

Description of additional methods and procedures used in the study. Also includes Supplementary References.
Supplementary Figure 1 from miR-892b Silencing Activates NF-κB and Promotes Aggressiveness in Breast Cancer
Authors: Jiang Lili , Yu Liang , Zhang Xin , Lei Fangyong , Wang Lan , Liu Xiangxia , Wu Shu , Zhu Jinrong , Wu Geyan , Cao Lixue , Liu Aibin , Song Libing , Li Jun
Published: March 2023

Supplementary Figure 1. Silencing miR-892b induces NF-kappaB activity in breast cancer cells.
Supplementary Figures 1 through 7 from FOXD1–ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells
Authors: Cheng Peng , Wang Jia , Waghmare Indrayani , Sartini Stefania , Coviello Vito , Zhang Zhuo , Kim Sung-Hak , Mohyeldin Ahmed , Pavlyukov Marat S. , Minata Mutsuko , Valentim Claudia L.L. , Chhipa Rishi Raj , Bhat Krishna P.L. , Dasgupta Biplab , La Motta Concettina , Kango-Singh Madhuri , Nakano Ichiro
Published: March 2023

Supplement Fig. S1. Original film scan of western blots in indicated figures; Supplementary Fig. S2. FOXD1 is identified as a MES GSC-representative transcription factor, related to Figure 1.; Supplementary Fig. S3. Glycolysis assay by measuring relative lactic acid levels of MES83 glioma spheres transduced with shNT control or shFOXD1#1; Supplementary Fig. S4. FOXD1 transcriptionally regulates the expression of ALDH1A3 in MES83 GSCs, related to Figure 4.; Supplementary Fig. S5. RNA-interference mediated silencing of ALDH inhibits tumorigenicity of Drosophila eye neoplasia, related to Figure 5.; Supplementary Fig. S6. Analysis of Rembrandt database showing a higher expression of ALDH1A3 associated with poor prognosis in glioma patients, related to Figure 6.; Supplementary Fig. S7. ALDH inhibitor GA11 inhibits the tumorigenicity of MES83 glioma spheres, related to Figure 6.
Supplementary Table and Figure Legends from Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines
Authors: Bakdash Ghaith , Buschow Sonja I. , Gorris Mark A.J. , Halilovic Altuna , Hato Stanleyson V. , Sköld Annette E. , Schreibelt Gerty , Sittig Simone P. , Torensma Ruurd , Duiveman-de Boer Tjitske , Schröder Christoph , Smits Evelien L. , Figdor Carl G. , de Vries I. Jolanda M.
Published: March 2023

Legends for Supplementary Tables S1-S2 and Supplementary Figures S1-S12.
Supplementary Table from Hyperthermia Synergizes with Chemotherapy by Inhibiting PARP1-Dependent DNA Replication Arrest
Authors: Schaaf Lea , Schwab Matthias , Ulmer Christoph , Heine Simon , Mürdter Thomas E. , Schmid Jens O. , Sauer Georg , Aulitzky Walter E. , van der Kuip Heiko
Published: March 2023

Table of TaqMan Assays (Applied Biosystems) used in this study
Supplementary Figure Legends from Hyperthermia Synergizes with Chemotherapy by Inhibiting PARP1-Dependent DNA Replication Arrest
Authors: Schaaf Lea , Schwab Matthias , Ulmer Christoph , Heine Simon , Mürdter Thomas E. , Schmid Jens O. , Sauer Georg , Aulitzky Walter E. , van der Kuip Heiko
Published: March 2023

Legends for Supplementary Figures 1-8
SUPPLEMENTARY DATA from Genome-Wide Association Study of Bladder Cancer in a Chinese Cohort Reveals a New Susceptibility Locus at 5q12.3
Authors: Wang Meilin , Li Zhiqiang , Chu Haiyan , Lv Qiang , Ye Dingwei , Ding Qiang , Xu Chuanliang , Guo Jianming , Du Mulong , Chen Jianhua , Song Zhijian , Yin Changjun , Qin Chao , Gu Chengyuan , Zhu Yao , Xia Guowei , Liu Fang , Zhang Zhengsheng , Yuan Lin , Fu Guangbo , Hu Zhibin , Tong Na , Shen Jiawei , Liu Ke , Sun Jielin , Sun Yinghao , Li Jue , Li Xingwang , Shen Hongbing , Xu Jianfeng , Shi Yongyong , Zhang Zhengdong
Published: March 2023

Supplemental Methods and References, Supplemental Tables S1-S10, Supplemental Figures S1-S11
Supporting data Fig 4A from Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic Response
Authors: Conery Andrew R. , Centore Richard C. , Spillane Kerry L. , Follmer Nicole E. , Bommi-Reddy Archana , Hatton Charlie , Bryant Barbara M. , Greninger Patricia , Amzallag Arnaud , Benes Cyril H. , Mertz Jennifer A. , Sims Robert J.
Published: March 2023

This file contains source data for the graph in Figure 4A (GI50 and expression values for each of the genes in 245 cell lines).
Figure S8 from Heme Oxygenase-1 Controls an HDAC4-miR-206 Pathway of Oxidative Stress in Rhabdomyosarcoma
Authors: Ciesla Maciej , Marona Paulina , Kozakowska Magdalena , Jez Mateusz , Seczynska Marta , Loboda Agnieszka , Bukowska-Strakova Karolina , Szade Agata , Walawender Magdalena , Kusior Magdalena , Stepniewski Jacek , Szade Krzysztof , Krist Bart , Yagensky Oleksandr , Urbanik Aleksandra , Kazanowska Bernarda , Dulak Jozef , Jozkowicz Alicja
Published: March 2023

Effect of co-culture of SMS-CTR eRMS cell line and mesenchymal stromal cells (MSC) with normal HO-1 expression (MSC WT) or lacking HO-1 (MSC HO-1 KO).
Supplementary Figure Legends from Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas
Authors: Bouillez Audrey , Rajabi Hasan , Pitroda Sean , Jin Caining , Alam Maroof , Kharbanda Akriti , Tagde Ashujit , Wong Kwok-Kin , Kufe Donald
Published: March 2023

Supplementary Figure Legends
Supplementary Table S1 from Ovarian Cancers Harboring Inactivating Mutations in CDK12 Display a Distinct Genomic Instability Pattern Characterized by Large Tandem Duplications
Authors: Popova Tatiana , Manié Elodie , Boeva Valentina , Battistella Aude , Goundiam Oumou , Smith Nicholas K. , Mueller Christopher R. , Raynal Virginie , Mariani Odette , Sastre-Garau Xavier , Stern Marc-Henri
Published: March 2023

Table S1A. Summary of alterations detected by WGS in 3 CDK12 mutated tumors; Table S1B. Summary for in-house mate-pair whole genome sequencing (WGS) runs
Supplementary Table 1 to 4 from Tissue Factor Induced by Epithelial–Mesenchymal Transition Triggers a Procoagulant State That Drives Metastasis of Circulating Tumor Cells
Authors: Bourcy Morgane , Suarez-Carmona Meggy , Lambert Justine , Francart Marie-Emilie , Schroeder Hélène , Delierneux Céline , Skrypek Nicolas , Thompson Erik W. , Jérusalem Guy , Berx Geert , Thiry Marc , Blacher Silvia , Hollier Brett G. , Noël Agnès , Oury Cécile , Polette Myriam , Gilles Christine
Published: March 2023

Supplementary Table 1: list of siRNA used. Supplementary Table 2: list of primers used. Supplementary Table 3: list of antibodies used in different applications. Supplementary Table 4: list of patients and donors information
Supplementary Materials and Methods from Tissue Factor Induced by Epithelial–Mesenchymal Transition Triggers a Procoagulant State That Drives Metastasis of Circulating Tumor Cells
Authors: Bourcy Morgane , Suarez-Carmona Meggy , Lambert Justine , Francart Marie-Emilie , Schroeder Hélène , Delierneux Céline , Skrypek Nicolas , Thompson Erik W. , Jérusalem Guy , Berx Geert , Thiry Marc , Blacher Silvia , Hollier Brett G. , Noël Agnès , Oury Cécile , Polette Myriam , Gilles Christine
Published: March 2023

Supplementary Materials and Methods